Center For Human Potential, P.a. | |
5301 Gulfport Blvd S Gulfport FL 33707-4947 | |
(727) 894-9777 | |
(727) 202-1010 |
Full Name | Center For Human Potential, P.a. |
---|---|
Speciality | Psychologist |
Location | 5301 Gulfport Blvd S, Gulfport, Florida |
Authorized Official Name and Position | Joseph G Baum (PRESIDENT) |
Authorized Official Contact | 7278949777 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Center For Human Potential, P.a. 5301 Gulfport Blvd S Gulfport FL 33707-4947 Ph: (727) 894-9777 | Center For Human Potential, P.a. 5301 Gulfport Blvd S Gulfport FL 33707-4947 Ph: (727) 894-9777 |
NPI Number | 1588838510 |
---|---|
Provider Enumeration Date | 04/22/2008 |
Last Update Date | 01/31/2015 |
Medicare PECOS PAC ID | 8628227741 |
---|---|
Medicare Enrollment ID | O20121005000207 |
News Archive
A drug used for rheumatoid arthritis has moved a step closer to FDA approval for a desperately needed new use.
Arthritis flares - the unpredictable and often sudden worsening of arthritis symptoms - can be debilitating. These episodes can make the management of inflammatory arthritis, which includes rheumatoid arthritis and psoriatic arthritis, challenging for patients and physicians.
Once again, the politics of birth control have trumped science and sound public policy. On Wednesday, the Obama administration overruled a carefully reasoned decision by the Food and Drug Administration to make the so-called morning-after pill available without prescription to adolescent girls below the age of 17.
Newborn infant girls have better outcomes than their male counterparts due to an innate genetic advantage in responding to acute infections, according to new research from RCSI.
› Verified 6 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1588838510 | NPI | - | NPPES |
010152 | Other | FL | VALUE OPTIONS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | PY4190 (Florida) | Primary |
Provider Name | Joseph Baum |
---|---|
Provider Type | Practitioner - Psychologist Billing Independently |
Provider Identifiers | NPI Number: 1508893249 PECOS PAC ID: 8628039765 Enrollment ID: I20041022000301 |
News Archive
A drug used for rheumatoid arthritis has moved a step closer to FDA approval for a desperately needed new use.
Arthritis flares - the unpredictable and often sudden worsening of arthritis symptoms - can be debilitating. These episodes can make the management of inflammatory arthritis, which includes rheumatoid arthritis and psoriatic arthritis, challenging for patients and physicians.
Once again, the politics of birth control have trumped science and sound public policy. On Wednesday, the Obama administration overruled a carefully reasoned decision by the Food and Drug Administration to make the so-called morning-after pill available without prescription to adolescent girls below the age of 17.
Newborn infant girls have better outcomes than their male counterparts due to an innate genetic advantage in responding to acute infections, according to new research from RCSI.
› Verified 6 days ago
Provider Name | Joseph Baum |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1508893249 PECOS PAC ID: 8628039765 Enrollment ID: I20121005000238 |
News Archive
A drug used for rheumatoid arthritis has moved a step closer to FDA approval for a desperately needed new use.
Arthritis flares - the unpredictable and often sudden worsening of arthritis symptoms - can be debilitating. These episodes can make the management of inflammatory arthritis, which includes rheumatoid arthritis and psoriatic arthritis, challenging for patients and physicians.
Once again, the politics of birth control have trumped science and sound public policy. On Wednesday, the Obama administration overruled a carefully reasoned decision by the Food and Drug Administration to make the so-called morning-after pill available without prescription to adolescent girls below the age of 17.
Newborn infant girls have better outcomes than their male counterparts due to an innate genetic advantage in responding to acute infections, according to new research from RCSI.
› Verified 6 days ago
News Archive
A drug used for rheumatoid arthritis has moved a step closer to FDA approval for a desperately needed new use.
Arthritis flares - the unpredictable and often sudden worsening of arthritis symptoms - can be debilitating. These episodes can make the management of inflammatory arthritis, which includes rheumatoid arthritis and psoriatic arthritis, challenging for patients and physicians.
Once again, the politics of birth control have trumped science and sound public policy. On Wednesday, the Obama administration overruled a carefully reasoned decision by the Food and Drug Administration to make the so-called morning-after pill available without prescription to adolescent girls below the age of 17.
Newborn infant girls have better outcomes than their male counterparts due to an innate genetic advantage in responding to acute infections, according to new research from RCSI.
› Verified 6 days ago
New Vision Behavioral Health Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1601 49th St S, Gulfport, FL 33707 Phone: 727-687-0997 | |
Dr. Katie Schubert, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6132 8th Ave S, Gulfport, FL 33707 Phone: 209-482-8567 |